BIO Praises FDA For Prioritizing Innovation In 2014-2018 Draft Goals List

FDA has laid out preliminary goals through 2018 that include increased oversight of regulated products; improved access to products that benefit health; promotion of better informed decisions about the use of medical products; and stronger organizational excellence and accountability. The goals, outlined in a draft strategic priority list that once finalized will drive the annual budget process, signal FDA will rely more on regulatory science to develop standards, enhance medical product tracing and improve consumer access to accurate health information...